Latest News

  • Alkermes’ Corporate Presentation to be Webcast at the Goldman Sachs 37th Annual Global Healthcare Conference Read More
  • Alkermes Appoints Nancy Snyderman, M.D., to Board of Directors Read More
  • Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230 Read More

Investors

Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes